MetLife Investment Management’s DXC Technology DXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$890K Buy
100,599
+97,842
+3,549% +$1.01M ﹤0.01% 1588
2026
Q1
$34.7K Sell
2,757
-67
-2% -$899 ﹤0.01% 2708
2025
Q4
$41.4K Sell
2,824
-168
-6% -$2.31K ﹤0.01% 2743
2025
Q3
$40.8K Buy
2,992
+4
+0.1% +$57 ﹤0.01% 2806
2025
Q2
$45.7K Sell
2,988
-227
-7% -$3.49K ﹤0.01% 2686
2025
Q1
$54.8K Buy
3,215
+73
+2% +$1.42K ﹤0.01% 2685
2024
Q4
$62.8K Buy
3,142
+9
+0.3% +$190 ﹤0.01% 2720
2024
Q3
$65K Sell
3,133
-116
-4% -$2.31K ﹤0.01% 2726
2024
Q2
$62K Sell
3,249
-518
-14% -$9.73K ﹤0.01% 2727
2024
Q1
$79.9K Sell
3,767
-216
-5% -$4.71K ﹤0.01% 2629
2023
Q4
$91.1K Sell
3,983
-46,860
-92% -$1.04M ﹤0.01% 2644
2023
Q3
$1.06M Sell
50,843
-6,930
-12% -$159K 0.01% 1198
2023
Q2
$1.54M Sell
57,773
-1,028
-2% -$25.6K 0.01% 1034
2023
Q1
$1.5M Sell
58,801
-1,277
-2% -$34.8K 0.01% 1018
2022
Q4
$1.59M Sell
60,078
-938
-2% -$26.1K 0.01% 995
2022
Q3
$1.49M Sell
61,016
-4,843
-7% -$133K 0.01% 1001
2022
Q2
$2M Sell
65,859
-642
-1% -$19.9K 0.02% 906
2022
Q1
$2.17M Buy
66,501
+10,773
+19% +$356K 0.01% 959
2021
Q4
$1.79M Sell
55,728
-1,166
-2% -$38K 0.01% 902
2021
Q3
$1.91M Sell
56,894
-2,181
-4% -$82.6K 0.02% 876
2021
Q2
$2.3M Sell
59,075
-1,594
-3% -$56.9K 0.02% 822
2021
Q1
$1.9M Sell
60,669
-1,116
-2% -$30.6K 0.02% 885
2020
Q4
$1.59M Sell
61,785
-2,663
-4% -$56.8K 0.02% 929
2020
Q3
$1.15M Sell
64,448
-1,916
-3% -$35K 0.01% 965
2020
Q2
$1.1M Buy
66,364
+378
+0.6% +$6.01K 0.01% 995
2020
Q1
$861K Sell
65,986
-2,019
-3% -$53.4K 0.01% 967
2019
Q4
$2.56M Sell
68,005
-3,284
-5% -$107K 0.03% 708
2019
Q3
$2.1M Sell
71,289
-2,656
-4% -$113K 0.02% 766
2019
Q2
$4.08M Sell
73,945
-154,829
-68% -$8.96M 0.04% 451
2019
Q1
$14.7M Buy
228,774
+148,667
+186% +$9.51M 0.04% 341
2018
Q4
$4.26M Sell
80,107
-1,684
-2% -$116K 0.05% 348
2018
Q3
$7.65M Sell
81,791
-2,045
-2% -$181K 0.08% 222
2018
Q2
$6.76M Sell
83,836
-15,404
-16% -$1.32M 0.08% 222
2018
Q1
$8.63M Sell
99,240
-2,793
-3% -$244K 0.1% 183
2017
Q4
$8.38M Buy
+102,033
New +$8.24M 0.09% 189

Other funds holding DXC

MetLife Investment Management's DXC Position: Q2 2026 in Review

MetLife Investment Management increased its DXC Technology (DXC) stake by 3,549% in Q2 2026, buying an estimated $1.01M and bringing the position to 100,599 shares worth $890K. The position accounts for ﹤0.01% of the portfolio, ranked #1588.

MetLife Investment Management first reported a position in DXC in Q4 2017 and has held it in 35 quarters since. The position peaked at $14.7M in Q1 2019. 436 funds tracked by Wall St. Rank hold DXC as of Q2 2026.

  • MetLife Investment Management held 100,599 shares of DXC Technology worth $890K as of Q2 2026.
  • MetLife Investment Management bought 97,842 DXC Technology shares in Q2 2026, an estimated $1.01M.
  • DXC Technology made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1588 holding.
  • MetLife Investment Management first reported a position in DXC Technology in Q4 2017 and has held it in 35 quarters since.
  • MetLife Investment Management's DXC Technology position peaked at $14.7M in Q1 2019.
  • 436 funds tracked by Wall St. Rank held DXC Technology as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.